Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CTSO
CYTOSORBENTS CORPORATION
NASDAQ
$0.37
▲ UP 18.93% (0.06)

KEY STATISTICS

Market Cap$23.25 M
52w High$1.04
52w Low$0.30
Dividend Yield—
Frequency—
P/E-1.32
Volume325.76K
Shares Out.62.84M

COMPANY

LEADERSHIP

Phillip Chan
CHIEF EXECUTIVE
Phillip Chan

COMPENSATION 2026

Salary$502,165
Stock Awards$105,600
Incentive Plan Pay$0
All Other Comp.$12,000
Total$808,431

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 8, 2006
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
129

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$9.90M
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2014-12-05Reverse1:25

PRICE

$0.37 ▲ UP 18.93% (+$0.06)
OVERLAYS
$0.32$0.34$0.36$0.389:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM0.37

About Cytosorbents Corporation

https://www.cytosorbents.com ↗

Cytosorbents develops blood purification devices like CytoSorb for sepsis, critical care, organ preservation, and blood safety, along with veterinary, renal, and contrast removal technologies.

INDUSTRY

Medical - Devices

A PRODUCT CYTOSORBENTS CORPORATION IS KNOWN FOR

CytoSorb
CytoSorb

CytoSorbents' flagship CytoSorb is an EU-approved extracorporeal cytokine adsorber targeting severe inflammation, with the U.S. focus on gaining approval for its DrugSorb-ATR device.

COMPETITORS

COMPETITOR
BAX COMPARE
FMS COMPARE
ICU COMPARE

Revenue by Products

IconPRODUCTQ4-2023Q1-2024Q2-2024Q3-2024
Grant income— $796.77K $1.05M ▲$777.59K ▼
Other sales$59.33K $24.73K ▼$11.4K ▼$26.52K ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
All Other Countries$6.56M $6.44M ▼$6.13M ▼$6.89M ▲
GERMANY$2.9M $2.7M ▼$2.61M ▼$2.54M ▼
UNITED STATES$28K $97.39K ▲$118K ▲$200K ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
13
LISTED HERE
3
RANKED BY POSITION SIZE
VTS.AX
0.00% · 1.3M
PQ
PQSG
0.16% · 3.0K
STSB
0.02% · 152

INSTITUTIONAL OWNERSHIP

SHARES OWNED
26.22%
HOLDERS
89
TOP 12 OF 89 · RANKED BY POSITION SIZE
Avenir Corp
5.2M sh · $3.34M
Vanguard Group Inc
2.2M sh · $1.41M
Skylands Capital, LLC
2.1M sh · $1.99M
Neuberger Berman Group LLC
1.7M sh · $950.78K
Cm Management, LLC
1.5M sh · $836.14K
Blackrock, Inc.
783.0K sh · $443.41K
Sargent Investment Group, LLC
738.7K sh · $690.02K
Geode Capital Management, LLC
707.3K sh · $400.62K
Blackrock Inc.
655.8K sh · $461.03K
Pathstone Holdings, LLC
500.0K sh · $283.12K
Jacob Asset Management Of New York LLC
197.9K sh · $372.13K
Cibc Private Wealth Group, LLC
172.6K sh · $110.36K

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
MARIANI PETER J
Purchase · 100.0K shares
2026-06-15
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Chan Phillip P.
Purchase · 10.3K shares
2026-06-15
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Chan Phillip P.
Purchase · 251.1K shares
2026-06-12
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Chan Phillip P.
Purchase · 100.0K shares
2025-11-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
NEUTRAL 1
2 GRADES IN THE LAST 12 MONTHS
D. Boral Capital BUY HC Wainwright & Co. NEUTRAL

SECTORS PEERS

PEERPRICE
BDSX$26.63COMPARE
ECOR$10.52COMPARE
TELO$1.13COMPARE
SRTS$3.34COMPARE
MDAI$1.60COMPARE
BDMD$1.16COMPARE
SER$2.87COMPARE
TELA$0.65COMPARE